Your browser doesn't support javascript.
loading
Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.
Ersche, Karen D; Roiser, Jonathan P; Abbott, Sanja; Craig, Kevin J; Müller, Ulrich; Suckling, John; Ooi, Cinly; Shabbir, Shaila S; Clark, Luke; Sahakian, Barbara J; Fineberg, Naomi A; Merlo-Pich, Emilio V; Robbins, Trevor W; Bullmore, Edward T.
Afiliação
  • Ersche KD; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom. Electronic address: ke220@cam.ac.uk.
  • Roiser JP; Institute of Cognitive Neuroscience, University College London, Cambridge, United Kingdom.
  • Abbott S; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; Department of Experimental Psychology, University of Cambridge, Cambridge, United Kingdom.
  • Craig KJ; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom.
  • Müller U; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
  • Suckling J; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom.
  • Ooi C; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom.
  • Shabbir SS; GlaxoSmithKline, Clinical Unit, Cambridge, United Kingdom.
  • Clark L; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; Department of Experimental Psychology, University of Cambridge, Cambridge, United Kingdom.
  • Sahakian BJ; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom.
  • Fineberg NA; Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, United Kingdom.
  • Merlo-Pich EV; Neurosciences Centre for Excellence in Drug Discovery, Verona, Italy.
  • Robbins TW; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; Department of Experimental Psychology, University of Cambridge, Cambridge, United Kingdom.
  • Bullmore ET; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; GlaxoSmithKline, Clinical Unit, Cambridge, United Kingdom.
Biol Psychiatry ; 70(8): 754-762, 2011 Oct 15.
Article em En | MEDLINE | ID: mdl-21967987

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulpirida / Mapeamento Encefálico / Imageamento por Ressonância Magnética / Comportamento Compulsivo / Transtornos Relacionados ao Uso de Anfetaminas / Transtornos Relacionados ao Uso de Cocaína / Corpo Estriado / Transtorno Obsessivo-Compulsivo Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Biol Psychiatry Ano de publicação: 2011 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulpirida / Mapeamento Encefálico / Imageamento por Ressonância Magnética / Comportamento Compulsivo / Transtornos Relacionados ao Uso de Anfetaminas / Transtornos Relacionados ao Uso de Cocaína / Corpo Estriado / Transtorno Obsessivo-Compulsivo Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Biol Psychiatry Ano de publicação: 2011 Tipo de documento: Article País de publicação: Estados Unidos